Alerts will be sent to your verified email
Verify Email
DPL
|
Dipna Pharma.
|
Deccan Health Care
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.1 % | 0.71 % | 11.5 % |
|
5yr average Equity Multiplier
|
14.87 | 1.17 | 3.23 |
|
5yr Average Asset Turnover Ratio
|
1.35 | 0.44 | 0.95 |
|
5yr Avg Net Profit Margin
|
0.81 % | 1.32 % | 4.98 % |
|
Price to Book
|
1.2 | 0.43 | 1.14 |
|
P/E
|
47.22 | 44.2 | 10.75 |
|
5yr Avg Cash Conversion Cycle
|
-33.62 Days | 287.43 Days | 217.93 Days |
|
Inventory Days
|
62.45 Days | 412.47 Days | 85.64 Days |
|
Days Receivable
|
112.8 Days | 66.84 Days | 186.74 Days |
|
Days Payable
|
139.84 Days | 105.94 Days | 98.82 Days |
|
5yr Average Interest Coverage Ratio
|
2.01 | 10.45 | 3.02 |
|
5yr Avg ROCE
|
12.33 % | 2.21 % | 18.94 % |
|
5yr Avg Operating Profit Margin
|
2.41 % | 8.19 % | 9.53 % |
|
5 yr average Debt to Equity
|
5.84 | 0.02 | 1.19 |
|
5yr CAGR Net Profit
|
117.34 % | 30.74 % | 55.85 % |
|
5yr Average Return on Assets
|
1.21 % | 0.62 % | 4.15 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
9.98 % | 18.42 % | 67.47 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-56.58 % | -16.47 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Dipna Pharma.
|
Deccan Health Care
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|